BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9034004)

  • 1. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia.
    Chen CH; Liu MY; Wei FC; Koong FJ; Hwu HG; Hsiao KJ
    Am J Med Genet; 1997 Feb; 74(1):40-3. PubMed ID: 9034004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis.
    Ma G; He Z; Fang W; Tang W; Huang K; Li Z; He G; Xu Y; Feng G; Zheng T; Zhou J; He L; Shi Y
    Schizophr Res; 2008 Apr; 101(1-3):26-35. PubMed ID: 18295456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.
    Malhotra AK; Goldman D; Buchanan RW; Rooney W; Clifton A; Kosmidis MH; Breier A; Pickar D
    Mol Psychiatry; 1998 Jan; 3(1):72-5. PubMed ID: 9491816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
    Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
    Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
    Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis.
    Utsunomiya K; Shinkai T; De Luca V; Hwang R; Sakata S; Fukunaka Y; Chen HI; Ohmori O; Nakamura J
    Neurosci Lett; 2008 Oct; 444(2):161-5. PubMed ID: 18703116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
    Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ
    Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients.
    Barlas IO; Cetin M; Erdal ME; Semiz UB; Basoglu C; Ay ME; Herken H; Uzun O
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jan; 150B(1):56-60. PubMed ID: 18449897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and schizophrenia in a Spanish sample.
    Lorenzo CV; Baca-Garcia E; Hernandez MD; Martin CB; Perez-Rodriguez MM; Saiz-Gonzalez MD; Fernández P; Gutierrez FJ; Saiz-Ruiz J; Piqueras JF; de Rivera JL; de Leon J
    Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):344-6. PubMed ID: 17171662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
    Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
    Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between the DRD3 Ser9Gly polymorphism and schizophrenia.
    Fathalli F; Rouleau GA; Xiong L; Tabbane K; Benkelfat C; Deguzman R; Zoltan D; Lal S; D'cruz S; Joober R
    Schizophr Res; 2008 Jan; 98(1-3):98-104. PubMed ID: 17698325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D3 receptor Ser9Gly polymorphism and risperidone response.
    Lane HY; Hsu SK; Liu YC; Chang YC; Huang CH; Chang WH
    J Clin Psychopharmacol; 2005 Feb; 25(1):6-11. PubMed ID: 15643094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis.
    Jönsson EG; Flyckt L; Burgert E; Crocq MA; Forslund K; Mattila-Evenden M; Rylander G; Asberg M; Nimgaonkar VL; Edman G; Bjerkenstedt L; Wiesel FA; Sedvall GC
    Psychiatr Genet; 2003 Mar; 13(1):1-12. PubMed ID: 12605094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia.
    Ishiguro H; Okuyama Y; Toru M; Arinami T
    Mol Psychiatry; 2000 Jul; 5(4):433-8. PubMed ID: 10889555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ser9Gly polymorphism in the dopamine D3 receptor gene is not associated with essential hypertension in the Japanese.
    Soma M; Nakayama K; Rahmutula D; Uwabo J; Sato M; Kunimoto M; Aoi N; Kosuge K; Kanmatsuse K
    Med Sci Monit; 2002 Jan; 8(1):CR1-4. PubMed ID: 11796958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.
    Steen VM; Løvlie R; MacEwan T; McCreadie RG
    Mol Psychiatry; 1997 Mar; 2(2):139-45. PubMed ID: 9106238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic variation in the human prodynorphin gene promoter and schizophrenia.
    Ventriglia M; Bocchio Chiavetto L; Bonvicini C; Tura GB; Bignotti S; Racagni G; Gennarelli M
    Neuropsychobiology; 2002; 46(1):17-21. PubMed ID: 12207142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations.
    Utsunomiya K; Shinkai T; Sakata S; Yamada K; Chen HI; De Luca V; Hwang R; Ohmori O; Nakamura J
    Neurosci Lett; 2012 Jan; 507(1):52-6. PubMed ID: 22172931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of new and reported data of the DRD3/MscI polymorphism: no support for the proposed association with schizophrenia.
    Hawi Z; McCabe U; Straub RE; O'Neill A; Kendler KS; Walsh D; Gill M
    Mol Psychiatry; 1998 Mar; 3(2):150-5. PubMed ID: 9577839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.